Several Actionable Targets Identified in Testicular Cancer
This video highlights recent research in cisplatin-resistant testicular cancer, including a study on whole exome sequencing that revealed several actionable targets.
Adjuvant TKI Use in High-Risk Clear Cell RCC Not Effective
Updated results of the ASSURE trial showed that adjuvant sunitinib or sorafenib did not improve disease-free survival among high-risk patients with renal cell carcinoma.
FDA Warns of Rare Cancer Linked to Breast Implants
The FDA has recently released a statement identifying a new rare T-cell lymphoma caused by breast implant surgery.
ASCO Statement Opposes Trump’s Recommended Budget Cuts to NIH
ASCO has released a statement announcing its opposition to President Trump’s budget outline for FY2018, which would cut about $6 billion in funding to the National Institutes of Health.
Novel Calculator Guides Treatment Choice in Esophageal Cancer
A novel calculator can more easily identify which esophageal adenocarcinoma patients derive an overall survival benefit from neoadjuvant chemoradiation to help guide treatment choices.
Genetic Variations Linked to Post-Transplant Outcomes in Leukemia Patients
This video examines research that found that certain genetic variations of both leukemia patients undergoing bone marrow transplant and their unrelated donors were associated with poor outcomes.
Stomach Pain in 67-Year-Old Patient
A 67-year-old man presents with gastric pain, and a biopsy is performed. What is your diagnosis?
Short-Course RT With Delayed Surgery Viable in Rectal Cancer
No difference in time to recurrence, recurrence-free survival, or overall survival were noted for patients with rectal cancer who underwent one of three different preoperative radiotherapy regimens.
Next-Generation Sequencing for Lung Cancer in Clinical Practice
This video highlights some of the latest developments guiding precision medicine for lung cancer in clinical practice.
Combined Immunotherapy, Thoracic RT Carries Moderate Toxicity in Lung Cancer
A study of the combination of radiation therapy and immune checkpoint inhibitors for the treatment of advanced lung cancer found a modest risk of side effects.
By clicking Accept, you agree to become a member of the UBM Medica Community.